NervGen Pharma
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | 29 | -10 | -10 | -9 |
EBITDA | 6,732 | -2,974 | -6,676 | -2,733 |
EBIT | 6,706 | -2,984 | -6,687 | -2,743 |
Net Income | -31,702 | -2,984 | -6,687 | -2,743 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -10,127 | -3,818 | -2,691 | -2,861 |
Cash | 22,069 | 8,159 | 11,513 | 10,055 |
Basic Shares | 72,330 | 73,162 | 71,956 | 70,666 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -58 | -109 | -84 | |
EBITDA | -5,651 | -16,623 | -16,777 | -14,822 |
EBIT | -5,707 | -16,681 | -16,887 | -14,907 |
Net Income | -44,117 | -16,681 | -16,887 | -15,286 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -19,499 | -11,702 | -8,526 | -13,134 |
Cash | 22,069 | 11,999 | 8,797 | 16,562 |
Basic Shares | 72,330 | 67,321 | 59,290 | 52,649 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.25 |
2025-12-31 | -$0.26 |
2025-09-30 | -$0.04 |
2025-06-30 | -$0.09 |